Sign in
4/A

Changes in Ownership

CG Oncology, Inc. Filed Acc 0001415889-24-010609

10% owner bought 400,000 shares at $19.00 ($7,600,000)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Decheng Capital Global Life Sciences Fund IV, L.P. 10% owner 2024-01-29 Purchase +400,000 $19.00 $7,600,000 4,958,810 D
Open-market purchases · 400,000 sh · avg $19.00 · $7,600,000
Loading xslF345X05/form4a-04092024_110416.xml…